D-penicillamine and neutrophilic agranulocytosis.
D000380:Agranulocytosis / Q000139:chemically induced*; D002648:Child; D005260:Female; D006527:Hepatolenticular Degeneration / Q000188:drug therapy; D006801:Humans; D009503:Neutropenia / Q000139:chemically induced*; D010396:Penicillamine / Q000009:adverse effects*
D010396:Penicillamine